163 related articles for article (PubMed ID: 22969298)
1. Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres.
Harsha S
Int J Nanomedicine; 2012; 7():4787-96. PubMed ID: 22969298
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization.
Harsha S
Drug Des Devel Ther; 2013; 7():1027-33. PubMed ID: 24101859
[TBL] [Abstract][Full Text] [Related]
3. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
Thombre NA; Gide PS
Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
Patel JK; Chavda JR
J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of pH triggers in situ porous controlled release micro balloon delivery of amoxicillin for eradication of Helicobacter pylori.
Tripathi GK; Singh S; Nath G; Dubey RK
Curr Drug Deliv; 2011 Nov; 8(6):667-77. PubMed ID: 22313162
[TBL] [Abstract][Full Text] [Related]
6. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
Patel JK; Patel MM
Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin.
Moogooee M; Ramezanzadeh H; Jasoori S; Omidi Y; Davaran S
J Pharm Sci; 2011 Mar; 100(3):1057-66. PubMed ID: 21280053
[TBL] [Abstract][Full Text] [Related]
8. Double-liposome-based dual-drug delivery system as vectors for effective management of peptic ulcer.
Jain AK; Agarwal A; Agrawal H; Agrawal GP
J Liposome Res; 2012 Sep; 22(3):205-14. PubMed ID: 22889385
[TBL] [Abstract][Full Text] [Related]
9. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
10. Erythromycin encapsulation in nanoemulsion-based delivery systems for treatment of Helicobacter pylori infection: Protection and synergy.
Tran LTC; Gueutin C; Frebourg G; Burucoa C; Faivre V
Biochem Biophys Res Commun; 2017 Nov; 493(1):146-151. PubMed ID: 28917836
[TBL] [Abstract][Full Text] [Related]
11. Development of antibacterial coating on silicone surface via chlorhexidine-loaded nanospheres.
Phuengkham H; Nasongkla N
J Mater Sci Mater Med; 2015 Feb; 26(2):78. PubMed ID: 25631275
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
Rajinikanth PS; Balasubramaniam J; Mishra B
Int J Pharm; 2007 Apr; 335(1-2):114-122. PubMed ID: 17141986
[TBL] [Abstract][Full Text] [Related]
13. Sequential release of salidroside and paeonol from a nanosphere-hydrogel system inhibits ultraviolet B-induced melanogenesis in guinea pig skin.
Peng LH; Xu SY; Shan YH; Wei W; Liu S; Zhang CZ; Wu JH; Liang WQ; Gao JQ
Int J Nanomedicine; 2014; 9():1897-908. PubMed ID: 24790432
[TBL] [Abstract][Full Text] [Related]
14. How to eradicate Helicobacter pylori using amoxicillin and omeprazole in the remnant stomach.
Rino Y; Imada T; Kabara T; Takahashi M; Shiozawa M; Ohshima T; Hasuo K; Inaba M; Yoneyama K; Yoshikawa T; Yukawa H; Kawamoto M; Tokunaga M; Takanashi Y
Hepatogastroenterology; 2003; 50(54):2267-9. PubMed ID: 14696514
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery system targeting Helicobacter pylori.
Abdelghany A; El-Desouky MA; Shemis M
Arab J Gastroenterol; 2021 Dec; 22(4):278-284. PubMed ID: 34509390
[TBL] [Abstract][Full Text] [Related]
16. Experimental design and optimization of a novel dual-release drug delivery system with therapeutic potential against infection with Helicobacter pylori.
Arrua EC; Sanchez SV; Trincado V; Hidalgo A; Quest AFG; Morales JO
Colloids Surf B Biointerfaces; 2022 May; 213():112403. PubMed ID: 35219219
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection.
Badhan AC; Mashru RC; Shah PP; Thakkar AR; Dobaria NB
AAPS PharmSciTech; 2009; 10(2):459-67. PubMed ID: 19381827
[TBL] [Abstract][Full Text] [Related]
18. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of pullulan-polycaprolactone core-shell nanospheres encapsulated with ciprofloxacin.
Shady SF; Gaines P; Garhwal R; Leahy C; Ellis E; Crawford K; Schmidt DF; McCarthy SP
J Biomed Nanotechnol; 2013 Sep; 9(9):1644-55. PubMed ID: 23980512
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO₂.
Patel J; Patil P
J Microencapsul; 2012; 29(4):398-408. PubMed ID: 22292967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
